IXHL 2.36 (+13.46%)
US45333L1061Drug ManufacturersDrug Manufacturers - Specialty & Generic

Incannex Healthcare (IXHL) Stock Highlights

2.36 | +13.46%
2024-10-21 05:36:07
Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Statistics

Range Today
1.98 2.37
Volume Today 88.9K
Range 1 Year
0.8 12.68
Volume 1 Year 27.82M
Range 3 Year
0.8 96.07
Volume 3 Year 52.15M
Range 10 Year
0.8 96.07
Volume 10 Year 52.15M

Highlights

Market Capitalization 41.64M (micro)
Floating Shares 13.43M
Current Price 2.36
Price To Earnings -1.8
Price To Revenue 3.01K
Price To Book 3.71
Earnings Per Share -1.15
Payout Ratio 0%

Performance

Latest +13.46%
1 Month +26.88%
3 Months -6.35%
6 Months -8.53%
1 Year +165.17%
3 Years -85.25%
5 Years -85.25%
10 Years -85.25%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.